This page includes the latest FDA filings for Foundation Medicine Inc 150 Second Streetcambridge Ma 02141 Pma Numberp200006 Supplement Numbers003 Date Received09 30 2022 Decision Date10 28 2022 Product Code Pqp Advisory Committee Pathology Supplement Typenormal 180 Day Track No User Fee Supplement Reason Postapproval Study Protocol Expedited Review Granted No. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
Device Company | Device | Date |
|---|---|---|
| Foundation Medicine, Inc.150 Second Streetcambridge, MA 02141 PMA NumberP200006 Supplement NumberS003 Date Received09/30/2022 Decision Date10/28/2022 Product Code PQP Advisory Committee Pathology Supplement Typenormal 180 Day Track No User Fee Supplement Reason Postapproval Study Protocol Expedited Review Granted? No | FoundationOne Liquid CDx (F1 Liquid CDx) | 2022-10-28 |